XML 23 R11.htm IDEA: XBRL DOCUMENT v3.23.2
Trade Receivables
 6 Months Ended
Jun. 30, 2023
Receivables [Abstract]  
Trade Receivables Trade Receivables
Product Sales
Receivables from product sales are recorded for amounts due to the Company related to sales of ORLADEYO and RAPIVAB. At June 30, 2023 and December 31, 2022, receivables related to sales of ORLADEYO were $55,482 and $41,508, respectively. At June 30, 2023 and December 31, 2022, receivables related to sales of RAPIVAB were $114 and $823, respectively. No reserve or allowance amounts were recorded as of June 30, 2023 and December 31, 2022.
Collaborations
Receivables from collaborations were as follows (in thousands):
June 30, 2023
BilledUnbilledTotal
U.S. Department of Health and Human Services, net$— $113 $113 
Royalty receivables from partners1,958 — 1,958 
Total receivables$1,958 $113 $2,071 
December 31, 2022
BilledUnbilledTotal
U.S. Department of Health and Human Services, net$7,218 $284 $7,502 
Royalty receivables from partners741 — 741 
Other collaborations— 25 25 
Total receivables$7,959 $309 $8,268 
As of both June 30, 2023 and December 31, 2022, the Company maintained a reserve of $437 related to royalties associated with Green Cross.